Carey Hwang

Carey Hwang

Company: Vir Biotechnology

Job title: Senior Vice President, Clinical Research, Head of Chronic Infection

Seminars:

The Potential Role of an Anti-HBs Antibody in Combination Therapy to Achieve Functional Cure in Chronic HBV 11:30 am

• Discuss how combination therapy is likely needed to achieve functional cure of chronic HBV by suppressing the virus and stimulating/enhancing the immune system • Evaluate how VIR-3434 is an HBV-neutralizing monoclonal antibody with multiple potential mechanisms of action including cross-presentation and stimulation of T cells (vaccinal effect) • Review in vitro, in vivo and…Read more

day: Day One

Panel Discussion: What, When & How? Pursuing Combination Therapy to Improve Durable Efficacy & Decrease Viral Breakthrough 8:30 am

• Sequencing multiple mechanisms of action acting on immune and viral targets to optimize therapeutic effect • Identifying effective combinations to achieve treatment with finite durations • Measuring toxicity and adverse events in combination therapy for HBVRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.